Form SC TO-I GROSVENOR REGISTERED Filed by: GROSVENOR REGISTERED MULTI-STRATEGY FUND (TI 1), LLC

Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

third-party tender offer subject to Rule 14d-1.

issuer tender offer subject to Rule 13e-4.

going-private transaction subject to Rule 13e-3.

amendment to Schedule 13D under Rule 13d-2.

The name of the issuer is Grosvenor Registered Multi-Strategy Fund (TI 1), LLC. The Fund is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as a closed-end, diversified, management investment company. It is organized as a Delaware limited liability company. The principal executive office of the Fund is located at 900 North Michigan Avenue, Suite 1100, Chicago, Illinois 60611 and the telephone number is (312) 506-6500.

The title of the securities that are the subject of the Offer is shares of limited liability company interest of the Fund (referred to herein as Shares). As of the start of business on September 1, 2022, there was approximately $135,350,143 in outstanding Shares. Subject to the conditions set forth in the Offer, the Fund will purchase up to $33,000,000 of Shares that are tendered by and not withdrawn by Investors, subject to any extension of the Offer.

Shares are not traded in any market, and any transfer thereof is strictly limited by the terms of the Fund’s Amended and Restated Limited Liability Company Agreement, as amended from time to time (the “LLC Agreement”).

The name of the filing person is Grosvenor Registered Multi-Strategy Fund (TI 1), LLC. The Fund’s principal executive office is located at 900 North Michigan Avenue, Suite 1100, Chicago, Illinois 60611 and the telephone number is (312) 506-6500. The president and principal financial officer of the Fund

are Scott J. Lederman and Kathleen P. Sullivan, respectively. Their address is c/o Grosvenor Registered Multi-Strategy (TI 1) Fund, LLC, 900 North Michigan Avenue, Suite 1100, Chicago, Illinois 60611 and the telephone number is (312) 506-6500. The management services provider to the Fund and the investment adviser of Grosvenor Registered Multi-Strategy Master Fund, LLC, in which the Fund invests substantially all of its assets (the “Master Fund”), is Grosvenor Capital Management, L.P. (the “Adviser”). The principal executive office of the Adviser is located at 900 North Michigan Avenue, Suite 1100, Chicago, Illinois 60611 and it may be reached at (312) 506-6500. The members of the Board are Henry S. Bienen, Alan Brott, Brian P. Gallagher, Scott J. Lederman, Victor J. Raskin and Thomas G. Yellin. Their address is c/o the Fund at 900 North Michigan Avenue, Suite 1100, Chicago, Illinois 60611 and their telephone number is (312) 506-6500.

Subject to the conditions set forth in the Offer, the Fund will purchase up to $33,000,000 of Shares that are tendered by Investors by 12:00 midnight, Eastern Time, on the Expiration Date, which is October 27, 2022, unless the Offer is extended, and not withdrawn.

The purchase price of Shares tendered and accepted for purchase will be their net asset value as of the close of business on the Valuation Date.

The scheduled expiration date of the Offer is 12:00 midnight, Eastern Time, October 27, 2022, unless extended.

Not applicable.

The Fund reserves the right, at any time and from time to time, to extend the period of time during which the Offer is pending by notifying Investors of the extension and the new Expiration Date. Reference is made to Section 8 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference.

Any Investor tendering Shares pursuant to the Offer may withdraw the tender at any time prior to the Expiration Date pursuant to Rule 13e-4 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Shares may be re-tendered, however, provided that such tenders are made before 12:00 midnight, Eastern Time, on the Expiration Date, which is October 27, 2022, unless the Offer is extended by following the tender procedures described herein. Pursuant to Rule 13e-4 of the Exchange Act, if the Fund has not yet accepted an Investor’s tender of Shares at any time on or before November 23, 2022 (i.e., 40 business days from the commencement of the Offer), an Investor may withdraw its tender of Shares after November 23, 2022.

Reference is made to Sections 5 and 6 of the Offer to Purchase that is attached as Exhibit B, which are incorporated herein by reference. A copy of: (a) the Cover Letter to the Offer to Purchase and the Letter of Transmittal; (b) the Offer to Purchase; (c) a form of Letter of Transmittal; (d) a form of Notice of Withdrawal of Tender; and (e) forms of Letters to Investors that will be sent in connection with the Fund’s acceptances of tenders of Shares, are attached hereto as Exhibits A, B, C, D and E, respectively.

For purposes of the Offer, the Fund will be deemed to have accepted for purchase Shares that are tendered as, if and when it gives written notice to the tendering Investors of its election to purchase such Shares.

Reference is made to Sections 4 and 8 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference.

Reference is made to Section 2 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference.

Not applicable.

Reference is made to Section 10 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference.

Not applicable.

To the Fund’s knowledge, no executive officer, director, or other affiliate plans to tender, and the Fund presently has no plans to purchase the Shares of any executive officer, director or other affiliate of the Fund pursuant to the Offer.

The Fund’s Prospectus and Statement of Additional Information, as updated and supplemented from time to time, and the LLC Agreement, provide that the Board has the discretion to determine whether the Fund will purchase Shares from time to time from Investors pursuant to written tenders. The Adviser expects that it will recommend to the Board that the Fund purchase Shares from Investors four times each year, effective as of the last business day of each calendar quarter. The Fund is not aware of any contract, arrangement, understanding or relationship relating, directly or indirectly, to this tender offer (whether or not legally enforceable) between: (i) the Fund, the Adviser, any director of the Fund or any person controlling the Fund or controlling the Adviser or any director of the Fund; and (ii) any other person, with respect to the Shares. However, the LLC Agreement provides that the Board will call a meeting of Investors for the purpose of determining whether the Fund should be dissolved in the event that the Fund does not at least once during any 24-month period repurchase any of the Shares tendered in accordance with the procedures determined by the Board from time to time.

Reference is made to Section 2 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference.

Reference is made to Section 2 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference.

Reference is made to Section 9 of the Offer to Purchase that is attached as Exhibit B, which is incorporated herein by reference. Because Shares are not traded in any market, Subsections (6), (7) and (8) of Item 1006(c) of Regulation M-A are not applicable to the Fund.

None.

Not applicable.

As of August 31, 2022, the Adviser or its affiliated corporate entities own 0.10% of the Fund’s outstanding Shares and none of the executive officers or Directors own any Shares.

Other than the issuance of Shares at net asset value in the ordinary course of the Fund’s offering on each of August 1, 2022, and September 1, 2022, and the previous tender offer for the repurchase of Shares, there have been no transactions involving the Shares that were effected during the past 60 days by the Fund, the Adviser, and any director or officer of the Fund, or any person controlling the Fund or the Adviser. The Fund’s previous tender offer for the repurchase of Shares had an expiration date of July 27, 2022.

No persons have been employed, retained or are to be compensated by the Fund to make solicitations or recommendations in connection with the Offer.

Not applicable.

Reference is made to the following financial statements of the Fund, which the Fund has prepared and furnished to Investors pursuant to Rule 30e-1 under the 1940 Act and filed with the Securities and Exchange Commission pursuant to Rule 30b2-1 under the 1940 Act, and which are incorporated by reference in their entirety for the purpose of filing this Schedule TO:

The Fund is not required to and does not file quarterly unaudited financial statements under the Securities Exchange Act of 1934, as amended.

Not applicable.

The Fund’s assets will be reduced by the amount of the tendered Shares that are purchased by the Fund. Thus, income relative to assets may be affected by the Offer.

(a)

Not applicable.

Not applicable.

None.

N/A.

N/A.

Cover Letter to the Offer to Purchase and the Letter of Transmittal.

Offer to Purchase.

Form of Letter of Transmittal.

Form of Notice of Withdrawal of Tender.

Forms of Letters to Investors in connection with the Fund’s acceptance of tenders of Shares.

Calculation of Filing Fee Tables.

Cover Letter to the Offer to Purchase and the Letter of Transmittal

Offer to Purchase

Form of Letter of Transmittal

Form of Notice of Withdrawal of Tender

Forms of Letters to Investors in connection with the Fund’s acceptance of tenders of Shares

Calculation of Filing Fee Tables